gene in patients relapsing just after cure Together with the BCL2 antagonist venetoclax. 66 Resistance to those agents has been linked to these mutations in all around 70% of scenarios, Whilst they are usually subclonal and their unique role causing resistance must be confirmed.Genetic susceptibility mechanisms. Most susceptibility loci map to non-